Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic vs nonâ€biologic systemic therapies
JEADV, 2021.
Mason KJ, Burden AD, Barker J, Lunt M, Ali H, Kleyn CE, McElhone K, Soliman MM, Green AC, Griffiths CEM, Reynolds NJ, Ormerod AD
Read publication: JEADV 2021
Related
Effectiveness and survival of methotrexate versus adalimumab in patients with moderate-to-severe pso...
Application of information theoretic feature selection and machine learning methods for the developm...
Age and biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the Br...
0 Comments